Search
Search
As cell culture processes mature, standard media may no longer support the specific needs of a given cell line or process. Shifts in productivity, growth performance, or product quality often reflect gaps between the formulation and the execution of the process at scale or under changing conditions. Media development can address this by tailoring formulations to defined process goals using established experimental workflows for cell culture medium development. By aligning media composition with cell line behavior and process requirements, development efforts can support improved performance, consistency, and manufacturability as programs progress.
Media development can be approached using different workflows depending on process maturity and the level of formulation insight required. Gibco Media by Design Services offers both traditional and multi-omics–guided workflows, allowing teams to select an approach aligned to their timelines, the questions they need to answer, and the current stage of development.
Media development is typically considered when screening, panel evaluations, or incremental optimization no longer supports defined process goals. Common decision points include stalled productivity gains, emerging product quality concerns, or constraints introduced as processes move toward scale-up. Media development may also be appropriate when preparing for manufacturing, establishing platform processes, or when greater control over consistency and performance is required as programs advance.
Media development incorporates manufacturing considerations early in the formulation design. Factors, such as scalability, raw material availability, formulation complexity, and format requirements, are evaluated alongside performance. Liquid, dry powder, and granular formats are assessed to align with handling, storage, and production workflows, supporting continuity as processes transition from non-cGMP development to cGMP manufacturing.
Traditional DoE-based workflows are often suitable when processes are well characterized, and targeted optimization is required. Multi-omics workflows may be appropriate when performance limitations are not well understood, when multiple variables appear to be interacting, or when deeper biological insight is needed to inform formulation decisions. Timelines and the nature of performance challenges, such as a hard-to-express molecule or high expression requirements, also are considerations.
Full-service media development projects are performed at Gibco facilities, where formulation design, cell culture experimentation, and data analysis are conducted by dedicated development teams. Consultative projects support customer-run experiments, with Gibco scientists offering help with experimental design, media formulation, and data interpretation. These engagement models allow teams to align project execution with internal resources and capabilities.
Media development helps in identifying components and attributes that influence performance or product quality. Optimized formulations can be advanced into rapid prototyping to evaluate manufacturability, format conversion, and scale behavior. Together, these activities support a structured transition into scalable cGMP manufacturing while maintaining alignment with upstream process requirements.
Media development is part of a broader set of upstream services designed to support process understanding and progression. Gibco Media by Design Services also includes analytics and screening capabilities that extend insight beyond formulation design.
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.